Top compounds associated with response to ASXL3


Feature Type Standardized
Nominal ANOVA
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA prochlorperazine CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.13 5e-05
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.13 5e-05
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.13 5e-05
Download CSV